ENPICOM introduces a powerful liability prediction solution to de-risk antibody development

The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling Caption:The IGX Platform to select better antibodies. To download image, please click here. ‘s-Hertogenbosch, The Netherlands – September 7, 2021 – Life Science Newswire – ENPICOM, an innovative bioinformatics software company, announced today at the Biologics UK conference new IGX... Read more

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

The new Antibody Discovery Module accelerates and improves candidate selection workflows Caption: ENPICOM’s solution accelerates and improves antibody discovery. To download image, please click here. ‘s-Hertogenbosch (The Netherlands) – January 28, 2020 – Life Science Newswire – ENPICOM BV, an innovative bioinformatics software engineering company, announces a major release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module (ADM). This... Read more